Log in to save to my catalogue

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486553

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

About this item

Full title

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of neurology, 2017-06, Vol.264 (6), p.1209-1217

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Currently, it has not been satisfactorily established, whether modern low-osmolality iodinated contrast agents (ICAs) used in computed tomography (CT) studies are a risk factor for exacerbation of myasthenic symptoms. The rate of acute adverse events as well as delayed clinical worsening up to 30 days were analyzed in 73 patients with confirmed mya...

Alternative Titles

Full title

Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486553

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5486553

Other Identifiers

ISSN

0340-5354

E-ISSN

1432-1459

DOI

10.1007/s00415-017-8518-8

How to access this item